SML2591

SCH-39166 hydrobromide

≥98% (HPLC), D1/D5 subtype-selective dopamine receptor antagonist , powder

• Synonym(e): (-)-trans-6,7,7a,8,9,13b-Hexahydro-3-chloro-2-hydroxy-N-methyl- 5H-benzo[d]naptho-(2,1-b)azepine hydrobromide, (6aS,13bR)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide, (6aS-trans)-11-Chloro-6,6a,7,8,9,13b-hexahydro-7-methyl-5H-Benzo[d]naphth[2,1-b]azepin-12-ol hydrobromide, Ecopipam hydrobromide, PSYRX 101 hydrobromide, PSYRX-101 hydrobromide, PSYRX101 hydrobromide, SCH 39166 hydrobromide, SCH39166 hydrobromide
• Empirische Formel (Hill-System): C₁₉H₂₀ClNO·HBr
• CAS-Nummer: 2587360-22-1
• Molekulargewicht: 394.73
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD08703109
• Assay: ≥98% (HPLC)
• Form: powder
• Storage condition: desiccated

Eigenschaften

• Produktname: SCH-39166 hydrobromide, ≥98% (HPLC)
• assay: ≥98% (HPLC)
• form: powder
• storage condition: desiccated
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear
• storage temp.: 2-8°C

Beschreibung

Biochem/physiol Actions

High-affinity D₁/D₅ subtype-selective dopamine receptor antagonist with in vitro and in vivo efficacy.

SCH-39166 (ecopipam) is a high-affinity D_1/D₅ subtype-selective dopamine receptor antagonist (K_i = 1.2 nM/D₁, 2.0 nM/D₅, 980 nM/D₂, 5.52 μM/D₄, 80 nM/5-HT, 731 nM/α_2a). SCH-39166 is widely employed both in cultures and in animal studies in vivo.

Sicherheitshinweise

• pictograms: GHS07
• signalword: Warning
• hcodes: H302,H315
• Hazard Classifications: Acute Tox. 4 Oral - Skin Irrit. 2
• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• pcodes: P264 - P280 - P301 + P312 - P302 + P352 - P332 + P313 - P362 + P364